Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
osteoporotic fractures | — | D058866 | — |
postmenopausal osteoporosis | EFO_0003854 | D015663 | — |
Expiration | Code | ||
---|---|---|---|
denosumab, Xgeva, Amgen Inc. | |||
2121-12-05 | Orphan excl. |
Code | Description |
---|---|
J0897 | Injection, denosumab, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteoporosis | D010024 | HP_0000939 | M81.0 | 5 | 15 | 21 | 22 | 14 | 75 |
Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | 4 | 4 | 18 | 13 | 11 | 50 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 6 | 11 | 8 | 2 | — | 27 |
Metabolic bone diseases | D001851 | HP_0000938 | — | 1 | 4 | 9 | 1 | 3 | 18 |
Neoplasms | D009369 | — | C80 | 2 | 4 | 5 | 1 | 2 | 13 |
Giant cell tumor of bone | D018212 | — | — | — | 3 | 2 | 2 | 3 | 10 |
Prostatic neoplasms | D011471 | — | C61 | 2 | 1 | 4 | 1 | — | 8 |
Castration-resistant prostatic neoplasms | D064129 | — | — | — | 2 | 4 | 1 | — | 7 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 1 | 2 | — | 1 | 1 | 5 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | 1 | — | 1 | 1 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | — | 5 | 2 | — | — | 7 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 3 | 1 | — | 1 | 5 |
Osteogenesis imperfecta | D010013 | — | Q78.0 | — | 1 | 2 | — | — | 3 |
Parathyroid neoplasms | D010282 | — | — | — | 1 | 1 | — | — | 2 |
Carcinoma | D002277 | — | C80.0 | — | 1 | 1 | — | — | 2 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | — | 1 | 1 | — | — | 2 |
Anorexia nervosa | D000856 | EFO_0004215 | F50.0 | — | — | 2 | — | — | 2 |
Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | — | 1 | 1 | — | — | 2 |
Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | 1 | — | 1 | 2 |
Systemic mastocytosis | D034721 | — | C96.21 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | 3 | — | — | — | 3 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | 2 | — | — | — | 2 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | — | 2 | — | — | — | 2 |
Melanoma | D008545 | — | — | 1 | 2 | — | — | — | 2 |
Aneurysmal bone cysts | D017824 | EFO_1001760 | M85.5 | 1 | 2 | — | — | — | 2 |
Male infertility | D007248 | EFO_0004248 | N46 | — | 2 | — | — | — | 2 |
Critical illness | D016638 | — | — | — | 1 | — | — | — | 1 |
Nasopharyngeal carcinoma | D000077274 | — | — | — | 1 | — | — | — | 1 |
Nasopharyngeal neoplasms | D009303 | — | — | — | 1 | — | — | — | 1 |
Smoldering multiple myeloma | D000075122 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 10 | — | — | — | — | 10 |
Male breast neoplasms | D018567 | — | — | 1 | — | — | — | — | 1 |
Breast density | D000071060 | — | — | 1 | — | — | — | — | 1 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
Aging | D000375 | GO_0007568 | R41.81 | 1 | — | — | — | — | 1 |
Replacement arthroplasty hip | D019644 | — | — | 1 | — | — | — | — | 1 |
Bone neoplasms | D001859 | EFO_0003820 | D16 | 1 | — | — | — | — | 1 |
Secondary hyperparathyroidism | D006962 | EFO_1001173 | — | 1 | — | — | — | — | 1 |
Hypocalcemia | D006996 | HP_0002901 | E83.51 | 1 | — | — | — | — | 1 |
Immunosuppression therapy | D007165 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteonecrosis | D010020 | EFO_0004259 | M87 | — | — | — | — | 2 | 2 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | — | — | — | — | 1 | 1 |
Bisphosphonate-associated osteonecrosis of the jaw | D059266 | — | — | — | — | — | — | 1 | 1 |
Infections | D007239 | EFO_0000544 | — | — | — | — | — | 1 | 1 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | — | 1 | 1 |
Menopause | D008593 | EFO_0003922 | N95 | — | — | — | — | 1 | 1 |
Mortality | D009026 | EFO_0004352 | — | — | — | — | — | 1 | 1 |
Drug therapy | D004358 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Denosumab |
INN | denosumab |
Description | Immunoglobulin G2, anti-(human tumor necrosis factor ligand superfamily member 11 (human osteoclast differentiation factor))(human monoclonal AMG162 heavy chain), disulfide with human monoclonal AMG162 light chain, dimer |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1237023 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB06643 |
UNII ID | 4EQZ6YO2HI (ChemIDplus, GSRS) |